Improving the quality and cost of diabetes care: How Florida Hospital System discovered and reduced hypoglycemia risks. Dr. Richard Pratley of Florida Hospital System (now AdventHealth Orlando) and Dr. Steven Edelman of UCSD. Hosted by American Hospital Association.
Successfully transitioning from sliding scale to basal bolus: Truths behind the journey and the results. Rose Newsom of Kaweah Delta Health Care District.
Clinicians and Patients Speak to the Efficacy, Safety and Value of Glytec’s eGlycemic Management System.
How much do hypoglycemic events cost your hospital every year? Let’s do the math!
Enter total number of annual discharges: Annual estimated cost: A study by the Agency for Healthcare Research and Quality (AHRQ) revealed that a single adverse drug event involving a hypoglycemic agent resulted in an average marginal cost of $4,312 for an inpatient stay.* To determine how this impacts your hospital on an annual basis, simply enter the total number of …
Successfully transitioning from sliding scale to basal bolus: Truths behind the journey and the results. Kaweah Delta Health Care District. Download a PDF of this compelling case study showcasing how Kaweah Delta Health Care District partnered with Glytec to achieve best practices in glycemic management.Download PDFSuccessfully transitioning from sliding scale to basal bolus: Truths behind the journey and the results. …
Clinical and financial impact of inpatient diabetes care and glycemic management in the ICU and Non-ICU. Dr. Guillermo Umpierrez of Emory University and Grady Health. TOPICTIME STAMPIntroducing Dr. Guiellermo Umpierrez00:00 Diabetes Research at Emory University01:18 Hypoglycemia in the ICU03:24 Clinical Inertia Surrounding Glycemic Control05:14 Current Glycemic Guidelines and Targets06:06 Reducing Complications for Cardiovascular Surgery Patients07:10 Reducing ICU Stay for Cardiovascular …
What do hospital executives say about using Glytec’s eGMS to combat the cost, quality and safety issues surrounding hypoglycemia?
Improvements in quality and safety of patient care through changes to insulin management protocols, including the transition from Monarch Medical Technologies’ EndoTool to Glytec’s Glucommander. MedPage Today interviews Dr. Valerie Garrett.
Gaining buy-in from hospital administration for a glycemic management initiative. Dr. Paul Chidester of Sentara Healthcare.
Hypoglycemia in hospitalized patients: Key issues and the prospect of a publicly-reported measure. Dr. Greg Maynard of UC Davis Medical Center. TOPICTIME STAMPIntroducing Dr. Greg Maynard and Topics Being Addressed00:00 Main Messages Concerning Hypoglycemia in Hospitalized Patients00:44 Association Between Hypoglycemia and Adverse Drug Events01:46 Four Primary Causes of Iatrogenic Hypoglycemia02:23 Devastating Effects of Hypoglycemia: A Real Patient Story03:07 Frequency of …
Clinical and financial outcomes of intensive glucose control for cardiac surgery patients, including results of the GLUCO-CABG Trial. Dr. Guillermo Umpierrez of Emory University and Grady Health.
Measuring the costs of hypoglycemia in hospitalized patients and impact on length of stay. MD Magazine interviews Dr. Jagdeesh Ullal.
Comparing Glucommander IV to usual care for treatment of diabetic ketoacidosis. Diabetes in Control interviews Dr. Joseph Aloi.
Use of integrated insulin algorithms for cardiovascular surgery patients, including reasons for replacing Monarch Medical Technologies’ EndoTool with Glytec’s Glucommander. MD Magazine interviews Dr. Valerie Garrett.
- Page 2 of 2